Security key
92337R101
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)
CUSIP: 92337R101
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Class A Common Stock, par value $0.001 per share
- Total 13F shares
- 39,258,779
- Total 13F value
- $538,195,352
- Share change
- +824,363
- Put/Call ratio
- 0%
- SEC-reported price per share
- $13.71
- Number of holders
- 84
- Value change
- +$9,620,413
- Number of buys
- 54
- Number of sells
- 23
- Shares outstanding
- 72,325,000
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
84
Top holders
10
VERA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Vera Therapeutics, Inc. SEC filings
Vera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92337R101
Recent filing periods:
Ownership snapshot
Top reported holders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
3/4/5
Lead comparable stake: 9%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
9%
Commodore Capital LP
7.5%
Sofinnova Investments, Inc.
4.8%
Kynam Capital Management, LP
4.1%
Carlyle Group Inc.
3.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
9%
|
$104,895,739
6,535,560 shares
|
— | 30 Jun 2023 |
| Commodore Capital LP |
13F
Company
|
7.5%
|
$87,472,500
5,450,000 shares
|
— | 30 Jun 2023 |
| Sofinnova Investments, Inc. |
13F
Company
|
4.8%
|
$55,647,854
3,467,156 shares
|
— | 30 Jun 2023 |
| Kynam Capital Management, LP |
13F
Company
|
4.1%
|
$48,150,000
3,000,000 shares
|
— | 30 Jun 2023 |
| Carlyle Group Inc. |
3/4/5
13F
10%+ Owner · Company
|
3.3%
from 13F
|
$53,284,158
2,960,231 shares
|
— | 17 Aug 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
3%
|
$34,830,651
2,170,134 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
84
Shares
39,258,779
Rows available
84
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
76
Q3 2023 holders
84
Holder diff
8
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend